journal article·2019-12-04Open access

Improved uptake and therapeutic intervention of curcumin via designing binary lipid nanoparticulate formulation for oral delivery in inflammatory bowel disorder

Manu Sharma, Shipra Sharma, Jyoti Wadhwa

Abstract

This study was focussed on development of curcumin loaded solid binary lipid nanoparticles (C-SBLNs) to ameliorate stability, uptake and therapeutic potential of curcumin during inflammatory bowel disease (IBD). C-SBLNs with nano-size range (210.56 ± 41.22 nm) and high entrapment efficiency (83.12 ± 6.57%) were prepared by solvent emulsification evaporation method using binary lipids i.e. stearic acid and tristearin after optimizing various formulation and process variables. Physicochemical characterization of C-SBLNs by ATR-FTIR confirmed drug entrapment whereas thermal and pXRD study corroborated loss of crystallinity of drug into C-SBLNs. Lyophilized C-SBLNs were found to be spherical shaped with good gastrointestinal stability and prolonged drug release up to 24 h. Optimized C-SBLNs formulation displayed significantly enhanced cellular uptake and localization in inflamed tissues during IBD. Oral administration of C-SBLNs in DSS induced colitis model revealed significant reduction in leucocyte infiltration, oxidative stress, pro-inflammatory cytokine (TNF-α) secretion and maintenance of colonic structure similar to healthy animal group compared to curcumin. Thus, in vitro and preclinical findings of study clearly confirmed that C-SBLNs could be a stable and efficacious alternative platform for curcumin delivery with strong competence in IBD chemotherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Curcumin's Biomedical Applications · Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacy, Banasthali Vidyapith

Department of Pharmaceutics, M. M. College of Pharmacy, Maharishi Markandeshwar University, Mullana

References (50)

Show source-provided references
1. 10.1038/nrgastro.2015.18610.1038/nrgastro.2015.186 ↗
2. 10.3748/wjg.v22.i27.629610.3748/wjg.v22.i27.6296 ↗
3. 10.1053/j.gastro.2008.01.01210.1053/j.gastro.2008.01.012 ↗
4. 10.1111/j.1751-2980.2010.00449.x10.1111/j.1751-2980.2010.00449.x ↗
5. 10.2147/DDDT.S1129010.2147/DDDT.S11290 ↗
6. 10.1371/journal.pone.017721110.1371/journal.pone.0177211 ↗
7. 10.3748/wjg.v23.i14.248310.3748/wjg.v23.i14.2483 ↗
8. 10.1371/journal.pone.013246710.1371/journal.pone.0132467 ↗
9. 10.1038/s41598-018-20179-610.1038/s41598-018-20179-6 ↗
10. 10.1016/j.fct.2009.03.00310.1016/j.fct.2009.03.003 ↗
11. 10.1007/978-0-387-46401-5_2010.1007/978-0-387-46401-5_20 ↗
12. 10.1158/1078-0432.CCR-04-074410.1158/1078-0432.CCR-04-0744 ↗
13. 10.3390/molecules1705597210.3390/molecules17055972 ↗
14. 10.1039/C7RA02861J10.1039/C7RA02861J ↗
15. 10.1208/s12249-009-9264-810.1208/s12249-009-9264-8 ↗
16. 10.1039/C5RA18112G10.1039/C5RA18112G ↗
17. 10.1016/j.ejpb.2017.03.01210.1016/j.ejpb.2017.03.012 ↗
18. 10.3109/03639045.2015.106494110.3109/03639045.2015.1064941 ↗
19. 10.1039/C7FO01616F10.1039/C7FO01616F ↗
20. 10.3109/10717544.2014.91867710.3109/10717544.2014.918677 ↗
21. 10.1080/21691401.2017.137365910.1080/21691401.2017.1373659 ↗
22. 10.1517/17425247.2014.93276910.1517/17425247.2014.932769 ↗
23. 10.3109/03639045.2014.88412710.3109/03639045.2014.884127 ↗
24. 10.1016/j.jconrel.2012.01.02810.1016/j.jconrel.2012.01.028 ↗
25. 10.1016/j.ijpharm.2013.05.01710.1016/j.ijpharm.2013.05.017 ↗
26. 10.1080/17425247.2016.117823710.1080/17425247.2016.1178237 ↗
27. 10.3748/wjg.v23.i23.420010.3748/wjg.v23.i23.4200 ↗
28. 10.1039/C6RA12841F10.1039/C6RA12841F ↗
29. 10.1039/C6RA07802H10.1039/C6RA07802H ↗
30. 10.1016/j.ejps.2010.01.01310.1016/j.ejps.2010.01.013 ↗
31. 10.1021/mp300649z10.1021/mp300649z ↗
32. 10.1007/BF0236123910.1007/BF02361239 ↗
33. 10.1371/journal.pone.006681410.1371/journal.pone.0066814 ↗
34. 10.1039/C7RA13555F10.1039/C7RA13555F ↗
35. 10.1016/S1357-2725(99)00034-510.1016/S1357-2725(99)00034-5 ↗
36. 10.1208/s12249-010-9563-010.1208/s12249-010-9563-0 ↗
37. 10.1016/j.colsurfb.2014.03.04610.1016/j.colsurfb.2014.03.046 ↗
38. 10.1016/j.ijpharm.2015.02.01310.1016/j.ijpharm.2015.02.013 ↗
39. 10.1016/S0378-5173(00)00378-110.1016/S0378-5173(00)00378-1 ↗
40. 10.1016/S0169-409X(01)00105-310.1016/S0169-409X(01)00105-3 ↗
41. 10.1016/j.ijpharm.2011.02.05110.1016/j.ijpharm.2011.02.051 ↗
42. 10.2147/IJN.S2398510.2147/IJN.S23985 ↗
43. 10.4155/tde.10.710.4155/tde.10.7 ↗
44. 10.1002/jps.2219110.1002/jps.22191 ↗
45. 10.1088/0957-4484/17/23/01810.1088/0957-4484/17/23/018 ↗
46. 10.1007/BF0298022810.1007/BF02980228 ↗
47. 10.1002/jps.2382810.1002/jps.23828 ↗
48. 10.1016/j.jconrel.2012.10.01910.1016/j.jconrel.2012.10.019 ↗
49. 10.1016/S0014-2999(01)01330-910.1016/S0014-2999(01)01330-9 ↗
50. 10.1155/2016/987529810.1155/2016/9875298 ↗